Published in Science on September 26, 1997
How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol (2001) 14.05
Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol (2007) 10.17
Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest (2004) 6.32
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest (2000) 5.26
Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest (2000) 4.90
Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med (2005) 4.31
Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci U S A (2000) 4.22
Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest (2000) 4.16
MMP12, lung function, and COPD in high-risk populations. N Engl J Med (2009) 3.96
An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med (2004) 3.12
Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest (2006) 3.11
Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol (2003) 2.66
A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J Immunol (2008) 2.58
Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J Clin Invest (2002) 2.52
Expression of the reverse tetracycline-transactivator gene causes emphysema-like changes in mice. Am J Respir Cell Mol Biol (2006) 2.46
How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol (2009) 2.46
Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest (1998) 2.43
Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med (2000) 2.36
Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice. Am J Physiol Lung Cell Mol Physiol (2008) 2.30
Mechanistic links between COPD and lung cancer. Nat Rev Cancer (2013) 2.28
Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. Lancet Respir Med (2014) 2.28
Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest (2008) 2.24
Matrix metalloproteinases in lung biology. Respir Res (2000) 2.18
Essential role of MMP-12 in Fas-induced lung fibrosis. Am J Respir Cell Mol Biol (2007) 2.16
Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol (2007) 2.14
Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev (2007) 2.14
Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol (2003) 2.12
Detection of emphysema in rat lungs by using magnetic resonance measurements of 3He diffusion. Proc Natl Acad Sci U S A (2000) 2.10
Toll-like receptor 4 deficiency causes pulmonary emphysema. J Clin Invest (2006) 2.08
Matrix metalloproteinases in destructive pulmonary pathology. Thorax (2005) 2.06
Molecular pathogenesis of emphysema. J Clin Invest (2008) 2.03
Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 2.01
TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem (2000) 2.00
Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study. Eur Heart J (2007) 1.99
A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med (2005) 1.96
Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J Clin Invest (2006) 1.94
Pathogenesis of chronic obstructive pulmonary disease. J Clin Invest (2012) 1.85
Physiology and pathophysiology of matrix metalloproteases. Amino Acids (2010) 1.83
Autophagy protein microtubule-associated protein 1 light chain-3B (LC3B) activates extrinsic apoptosis during cigarette smoke-induced emphysema. Proc Natl Acad Sci U S A (2010) 1.82
Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest (2001) 1.78
MMPs as therapeutic targets--still a viable option? Semin Cell Dev Biol (2007) 1.78
Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax (2005) 1.76
Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J Exp Med (2000) 1.70
Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema. Nat Med (2010) 1.67
Z α1-antitrypsin confers a proinflammatory phenotype that contributes to chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.65
The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc (2007) 1.65
Superoxide dismutase expression attenuates cigarette smoke- or elastase-generated emphysema in mice. Am J Respir Crit Care Med (2005) 1.61
IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS One (2011) 1.61
Fibulin-5/DANCE has an elastogenic organizer activity that is abrogated by proteolytic cleavage in vivo. J Cell Biol (2007) 1.60
Development of chronic bronchitis and emphysema in beta-epithelial Na+ channel-overexpressing mice. Am J Respir Crit Care Med (2007) 1.60
Matrix metalloproteinases: old dogs with new tricks. Genome Biol (2003) 1.59
Failure of elastic fiber homeostasis leads to pelvic floor disorders. Am J Pathol (2006) 1.55
Epithelium-specific deletion of TGF-β receptor type II protects mice from bleomycin-induced pulmonary fibrosis. J Clin Invest (2010) 1.54
Novel proteolytic microvesicles released from human macrophages after exposure to tobacco smoke. Am J Pathol (2013) 1.54
Chronic obstructive pulmonary disease * 3: Experimental animal models of pulmonary emphysema. Thorax (2002) 1.51
Progress in chronic obstructive pulmonary disease genetics. Proc Am Thorac Soc (2006) 1.51
Oxidants and signaling by mitogen-activated protein kinases in lung epithelium. Am J Respir Cell Mol Biol (2006) 1.51
N-alpha-PGP and PGP, potential biomarkers and therapeutic targets for COPD. Respir Res (2009) 1.50
Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis. Am J Pathol (1998) 1.48
Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. Am J Pathol (2002) 1.45
Chronic obstructive pulmonary disease - part 2: pathology and biochemistry of emphysema. Thorax (2002) 1.44
A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. J Clin Invest (2005) 1.43
Macrophage elastase kills bacteria within murine macrophages. Nature (2009) 1.42
Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest (2013) 1.42
Models of chronic obstructive pulmonary disease. Respir Res (2004) 1.42
Cigarette smoke-induced emphysema in A/J mice is associated with pulmonary oxidative stress, apoptosis of lung cells, and global alterations in gene expression. Am J Physiol Lung Cell Mol Physiol (2009) 1.40
IL-1α/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice. PLoS One (2011) 1.37
Role of CCR5 in IFN-gamma-induced and cigarette smoke-induced emphysema. J Clin Invest (2005) 1.37
Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation. Int J Chron Obstruct Pulmon Dis (2011) 1.34
The genetics of chronic obstructive pulmonary disease. Respir Res (2001) 1.33
Chronic obstructive pulmonary disease (COPD) and occupational exposures. J Occup Med Toxicol (2006) 1.33
A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest (2000) 1.30
Disruption of p21 attenuates lung inflammation induced by cigarette smoke, LPS, and fMLP in mice. Am J Respir Cell Mol Biol (2008) 1.30
Matrix metalloproteinase-8 inactivates macrophage inflammatory protein-1 alpha to reduce acute lung inflammation and injury in mice. J Immunol (2009) 1.30
Shape of tropoelastin, the highly extensible protein that controls human tissue elasticity. Proc Natl Acad Sci U S A (2011) 1.29
The stumbling block in lung repair of emphysema: elastic fiber assembly. Proc Am Thorac Soc (2006) 1.28
Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs. Thorax (2007) 1.28
Matrix metalloproteinase 12 overexpression in lung epithelial cells plays a key role in emphysema to lung bronchioalveolar adenocarcinoma transition. Cancer Res (2009) 1.27
Pathogenesis of emphysema: from the bench to the bedside. Proc Am Thorac Soc (2008) 1.26
Distal airways in mice exposed to cigarette smoke: Nrf2-regulated genes are increased in Clara cells. Am J Respir Cell Mol Biol (2008) 1.25
Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required? Respir Res (2005) 1.25
Epilysin (MMP-28) restrains early macrophage recruitment in Pseudomonas aeruginosa pneumonia. J Immunol (2009) 1.25
Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae. Infect Immun (2009) 1.22
Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting. Nat Rev Drug Discov (2009) 1.21
Airway obstruction is increased in pneumocystis-colonized human immunodeficiency virus-infected outpatients. J Clin Microbiol (2009) 1.20
Macrophage heterogeneity in respiratory diseases. Mediators Inflamm (2013) 1.20
Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice. Infect Immun (2008) 1.18
Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery. Br J Pharmacol (2009) 1.18
Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15. J Immunol (2010) 1.18
Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2008) 1.18
Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice. J Clin Invest (2011) 1.17
Protective effects of matrix metalloproteinase-12 following corneal injury. J Cell Sci (2013) 1.17
Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD. Respir Res (2007) 1.16
Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease. J Clin Invest (2009) 1.16
The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema. Am J Respir Crit Care Med (2010) 1.16
Overexpression of human matrix metalloproteinase-12 enhances the development of inflammatory arthritis in transgenic rabbits. Am J Pathol (2004) 1.16
Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome. Am J Pathol (2000) 1.16
A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis. J Allergy Clin Immunol (2013) 1.16
Cigarette smoke exposure impairs dendritic cell maturation and T cell proliferation in thoracic lymph nodes of mice. J Immunol (2008) 1.15
Matrix metalloproteinases -8, -9 and -12 in smokers and patients with stage 0 COPD. Int J Chron Obstruct Pulmon Dis (2007) 1.15
MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell (1998) 9.70
Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J (2003) 6.23
Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest (2000) 4.90
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med (1999) 4.85
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med (2001) 4.71
Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest (2000) 4.16
Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med (1998) 4.04
Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest (1982) 3.77
Chemotactic activity of elastin-derived peptides. J Clin Invest (1980) 3.33
Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A (1981) 3.03
Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci U S A (1996) 2.93
Ciliogenesis and left-right axis defects in forkhead factor HFH-4-null mice. Am J Respir Cell Mol Biol (2000) 2.90
Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci U S A (1999) 2.80
K-ras activation generates an inflammatory response in lung tumors. Oncogene (2006) 2.78
Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem (1991) 2.71
Contribution of monocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium. Circ Res (2000) 2.66
Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem (1993) 2.56
Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J Clin Invest (1990) 2.56
Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol (1989) 2.54
The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell (2000) 2.49
Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest (1998) 2.43
Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med (2000) 2.36
Chemotactic activity of platelet alpha granule proteins for fibroblasts. J Cell Biol (1983) 2.28
Mechanical ventilation with or without 7-day circuit changes. A randomized controlled trial. Ann Intern Med (1995) 2.26
Matrix metalloproteinases in lung biology. Respir Res (2000) 2.18
A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation. Crit Care Med (1997) 2.18
Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem (1997) 2.00
Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase. Science (2000) 1.97
Elastase release from human alveolar macrophages: comparison between smokers and nonsmokers. Science (1977) 1.97
Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med (1998) 1.96
The induction of pulmonary emphysema with human leukocyte elastase. Am Rev Respir Dis (1977) 1.95
Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci U S A (1996) 1.92
Proteolysis by neutrophils. Relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro. J Clin Invest (1982) 1.90
Matrix metalloproteinases generate angiostatin: effects on neovascularization. J Immunol (1998) 1.87
Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nat Med (2001) 1.81
Electron microscopic alterations at the alveolar level in pulmonary edema. Circ Res (1967) 1.80
Characterization of the mannose/fucose receptor on human mononuclear phagocytes. J Reticuloendothel Soc (1982) 1.78
Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest (1986) 1.72
Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. Am J Respir Cell Mol Biol (1999) 1.69
Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. J Cell Biol (1984) 1.66
In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med (1988) 1.64
Elastin degradation by matrix metalloproteinases. Cleavage site specificity and mechanisms of elastolysis. J Biol Chem (1997) 1.62
Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J Clin Invest (1985) 1.61
Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity. JAMA (1976) 1.60
Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol (1998) 1.60
Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am J Pathol (2000) 1.59
Matrix metalloproteinases. Matrix degradation and more. Am J Respir Cell Mol Biol (1999) 1.57
Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. J Biol Chem (1992) 1.57
Normal neutrophil function in cathepsin G-deficient mice. Blood (1999) 1.53
The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. J Biol Chem (1996) 1.53
Chronic obstructive pulmonary disease * 3: Experimental animal models of pulmonary emphysema. Thorax (2002) 1.51
Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease. Inflamm Res (2005) 1.50
Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis. Am J Pathol (1998) 1.48
Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. Science (1987) 1.47
Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc Natl Acad Sci U S A (1999) 1.46
Receptor-mediated binding and internalization of leukocyte elastase by alveolar macrophages in vitro. J Clin Invest (1979) 1.46
Biochemical quantitation of the chemotactic factor inactivator activity in human serum. J Lab Clin Med (1979) 1.46
End-stage chronic obstructive pulmonary disease: the cigarette is burned out but inflammation rages on. Am J Respir Crit Care Med (2001) 1.45
Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling. Biochem J (1999) 1.45
Deletions of the long arm of chromosome 10. Am J Med Genet (1985) 1.44
Chronic obstructive pulmonary disease - part 2: pathology and biochemistry of emphysema. Thorax (2002) 1.44
Elastase of U-937 monocytelike cells. Comparisons with elastases derived from human monocytes and neutrophils and murine macrophagelike cells. J Clin Invest (1982) 1.41
The induction of emphysema with elastase. II. Changes in connective tissue. Lab Invest (1976) 1.40
Chemotactic factor inactivators of human granulocytes. J Clin Invest (1977) 1.40
Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. J Clin Invest (1987) 1.35
Developmental expression of latent transforming growth factor beta binding protein 2 and its requirement early in mouse development. Mol Cell Biol (2000) 1.34
Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J Immunol (1991) 1.34
Intraoral findings and anomalies in neonates. Pediatrics (1982) 1.32
The application of Starling's law of capillary exchange to the lungs. J Clin Invest (1967) 1.30
A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest (2000) 1.30
Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression. J Biol Chem (1995) 1.30
Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. J Biol Chem (2000) 1.29
The carboxyl-terminal tridecapeptide of platelet factor 4 is a potent chemotactic agent for monocytes. Biochem Biophys Res Commun (1982) 1.28
Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. J Clin Invest (1990) 1.28
Chemotactic responses of fibroblasts to tropoelastin and elastin-derived peptides. J Clin Invest (1982) 1.27
Theophylline toxicity due to impaired theophylline degradation. Am Rev Respir Dis (1974) 1.27
The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites. Biochemistry (2001) 1.25
The elastin receptor shows structural and functional similarities to the 67-kDa tumor cell laminin receptor. J Biol Chem (1989) 1.24
Degradation of entactin by matrix metalloproteinases. Susceptibility to matrilysin and identification of cleavage sites. J Biol Chem (1993) 1.24
Patient transport from intensive care increases the risk of developing ventilator-associated pneumonia. Chest (1997) 1.23
Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP). J Biol Chem (1995) 1.23
The collagen substrate specificity of rat uterus collagenase. J Biol Chem (1983) 1.20
Developmental regulation of the human cathepsin G gene in myelomonocytic cells. J Biol Chem (1990) 1.19
Recruitment of osteoclast precursors by purified bone matrix constituents. J Cell Biol (1982) 1.18
Nicotine is chemotactic for neutrophils and enhances neutrophil responsiveness to chemotactic peptides. Science (1984) 1.18
Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity. Ann N Y Acad Sci (1999) 1.16
Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome. Am J Pathol (2000) 1.16
Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells. Am J Pathol (1979) 1.16
Neurofibromatosis: oral and radiographic manifestations. Oral Surg Oral Med Oral Pathol (1984) 1.15